Law ❯ Litigation ❯ Securities Law
Investor Rights Shareholder Rights Securities Fraud Investor Protection Corporate Governance Legal Representation Corporate Fraud Investor Claims Securities Class Action Cytokinetics, Incorporated
The complaint says NuScale misled investors about ENTRA1’s experience, citing a $495 million payment disclosure that preceded share losses.